The 2022 CDC opioid prescription guideline update: Relevant recommendations and future considerations

Ameya Gangal¹, Benjamin Stoff^{1

2}, Travis Blalock¹

Affiliations

Editorial

Ameya Gangal et al. JAAD Int. 2023.

. 2023 Jul 21:13:48-49.

doi: 10.1016/j.jdin.2023.07.006. eCollection 2023 Dec.

Ameya Gangal¹, Benjamin Stoff^{1

2}, Travis Blalock¹

¹ Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
² Emory Center for Ethics, Atlanta, Georgia.

No abstract available

Keywords: dermatologic surgery; drug monitoring; hidradenitis suppurativa; opioid; pain management; prescriber habits.

Conflict of interest statement

None disclosed.

1. Dowell D., Ragan K.R., Jones C.M., Baldwin G.T. Centers for Disease Control and Prevention; 2022. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. - PMC - PubMed
1. Gupta M.A., Gupta A.K., Vujcic B., Piccinin M. Use of opioid analgesics in skin disorders: results from a nationally representative US sample. J Dermatolog Treat. 2015;26:269–274. - PubMed
1. Voss V.B., Oh C., Veerabagu S., Nugent S., Giordano C., Golda N.J. Bupivacaine to reduce pain and narcotic use after Mohs micrographic surgery. Dermatol Surg. 2022;48:1135–1139. - PubMed
1. Cao S., Karmouta R., Li D.G., Din R.S., Mostaghimi A. Opioid prescribing patterns and complications in the dermatology Medicare population. JAMA Dermatol. 2018;154:317–322. - PMC - PubMed
1. McLawhorn J.M., Stephany M.P., Bruhn W.E., et al. An expert panel consensus on opioid-prescribing guidelines for dermatologic procedures. J Am Acad Dermatol. 2020;82:700–708. - PubMed